Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 91

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 91
---
 using its proprietary formulation Gemini. We have multiple ongoing programs to evaluate Gemini, including GEM -AKIas a prevention for acute kidney injury, GEM -CKDas a treatment for chronic kidney disease, GEM -PSIas a prevention for post surgical infection and GEM -PBIas a prevention of infection in severe burn patients requiring hospitalization. The Company was incorporated in the state of Delaware on November 20, 2019 (originally as Petra Acquisition, Inc.) and is based in San Diego, California. Our common stock and warrants sold in our initial public offering (“Public Warrants”) are listed on The Nasdaq Stock Market, LLC (“Nasdaq”) under the ticker symbol “REVB” and “REVBW,” respectively. Recent Developments 2025 Reverse Stock Split On January 17, 2025, at a special meeting of stockholders, our stockholders approved a Certificate of Amendment to our Third Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock at a specific ratio within a range of one -for -two(1 -for-2) to a maximum of a one -for -fifty(1 -for-50) split. Following the special meeting of stockholders and determination by the Board of Directors on the reverse split ratio, we filed a Certificate of Amendment effective on January 28, 2025, which effected a 1 -for-16reverse stock split of our outstanding shares of common stock as of 12:01 a.m. Eastern Standard Time on January 28, 2025. 2024 Reverse Stock Split On January 17, 2024, at a special meeting of stockholders, our stockholders approved a Certificate of Amendment to our Third Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock at a specific ratio within a range of one -for -two(1 -for-2) to a maximum of a one -for -fifty(1 -for-50) split. On January 22, 2024, we filed the Certificate of Amendment which effected a 1 -for-30reverse stock split of our outstanding shares of common stock as of 12:01 a.m. Eastern Standard Time on January 25, 2024. 2023 Change in Authorized Shares and Reverse Stock Split On January 30, 2023, at a special meeting of stockholders, our stockholders approved